Pfizer to expand in Sanford for gene-therapy medications


Gene therapy focuses on specialized, one-time treatments to address diseases caused by genetic mutation.   Contributed image

Pfizer Inc. plans to expand in North Carolina's Lee County to manufacture new gene-therapy medications.

Gov. Roy Cooper said the company intends to invest $100 million and create 40 new jobs during the expansion project in Sanford.

“North Carolina is one of the few places in the country with the biotech resources to take an idea all the way from the lab to the manufacturing line,” Cooper said. “Pfizer’s investment in Lee County is a prime example of how North Carolina’s world-class universities and cutting-edge industries work together to move our state forward.”

Gene therapy focuses on specialized, one-time treatments to address diseases caused by genetic mutation. In gene therapy, new genetic material is introduced into the body to correct a patient's cells as needed.

“Pfizer is proud to further expand our presence in North Carolina, particularly as we build our leadership in gene therapy,” Lynn Bottone, site leader at Pfizer Sanford, said. “We look forward to the next phase of this expansion as we build a clinical and commercial manufacturing facility.” 

A $250,000 performance-based grant of $250,000 from the One North Carolina Fund will help fund the expansion. Once the project is complete and all new positions are filled, it is expected to amount to $3.9 million in new payroll each year. 

Want to get notified whenever we write about Pfizer ?

Sign-up Next time we write about Pfizer, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.

Organizations in this Story

Pfizer

More News

Metro Business Network